Reticulocalbin 2 as a Potential Biomarker and Therapeutic Target for Atherosclerosis
Jing Li(Shandong University), Weibin Shi(University of Virginia)
Cited by 12
Related Papers
Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes
|Nature Communications|2019|72
White matter integrity mediates the associations between white matter hyperintensities and cognitive function in patients with silent cerebrovascular diseases
|CNS Neuroscience & Therapeutics|2022|11
VirusImmu: a novel ensemble machine learning approach for viral immunogenicity prediction
|bioRxiv (Cold Spring Harbor Laboratory)|2023|3